Research
Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.
Latest stories
Featured News
April 30, 2025
Transplant
April 30, 2025
Cardiovascular
April 29, 2025
Individualized Medicine
April 23, 2025
Individualized Medicine
April 22, 2025
Individualized Medicine
April 17, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community